"controllo green pass"

During the past decade, Sezione di Ematologia - Med.II Div. Presidio Ospedaliero S. Chiara di Trento conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Sezione di Ematologia - Med.II Div. Presidio Ospedaliero S. Chiara di Trento" are "BCR-ABL Positive" (1 trials), "Chronic Myeloid Leukaemia" (1 trials), "Chronic Myeloid Leukemia" (1 trials), "Chronic Phase Philadelphia Positive" (1 trials) and "Pregnancy" (1 trials). Many other conditions were trialed in "Sezione di Ematologia - Med.II Div. Presidio Ospedaliero S. Chiara di Trento" in a lesser frequency.

The vast majority of trials in "Sezione di Ematologia - Med.II Div. Presidio Ospedaliero S. Chiara di Trento" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Sezione di Ematologia - Med.II Div. Presidio Ospedaliero S. Chiara di Trento". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Sezione di Ematologia - Med.II Div. Presidio Ospedaliero S. Chiara di Trento, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Sezione di Ematologia - Med.II Div. Presidio Ospedaliero S. Chiara di Trento, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".